Clinical Trials

Carcinoma, Intraductal, Noninfiltrating

NCT00601900 2025-05-23

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

394 enrolled 11 charts

Breast Neoplasms

NCT00005970 2020-08-14

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

3,436 enrolled

Breast Neoplasms

NCT00041080 2019-07-30

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

139 enrolled 10 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00590785 2017-08-25

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

60 enrolled

Breast Neoplasms

NCT00003418 2013-12-19

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

4,400 enrolled

Breast Neoplasms

NCT00003678 2013-12-19

Tamoxifen in Treating Women With Breast Cancer

20,000 enrolled

Breast Neoplasms

NCT00010140 2013-12-18

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Breast Neoplasms

NCT00002579 2013-11-06

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer

2,000 enrolled

Breast Neoplasms

NCT00002580 2013-11-06

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

1,000 enrolled

Breast Neoplasms

NCT00002581 2013-11-06

Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer

1,000 enrolled

Breast Neoplasms

NCT00002755 2013-11-06

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

600 enrolled

Breast Neoplasms

NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

350 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

300 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00002720 2013-09-20

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer

642 enrolled

Breast Neoplasms

NCT00003013 2013-09-17

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

450 enrolled

Breast Neoplasms

NCT00002460 2013-08-07

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Breast Neoplasms

NCT00006030 2013-08-07

Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer

Breast Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

2,500 enrolled

Breast Neoplasms

NCT00002582 2013-08-02

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

6,000 enrolled

Breast Neoplasms

NCT00032136 2013-08-02

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

4,400 enrolled

Breast Neoplasms

NCT00003424 2013-06-26

Tamoxifen in Treating Patients With Primary Liver Cancer

300 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00002967 2013-06-21

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00047099 2013-05-30

Combination Chemotherapy in Treating Women With Breast Cancer

446 enrolled

Breast Neoplasms

NCT00016276 2013-01-16

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Phase 3 Terminated

396 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms, Cardiotoxicity

NCT00002646 2012-01-05

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

1,500 enrolled

Breast Neoplasms

NCT00003016 2009-02-09

Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer

20,000 enrolled